Drugmaker Bristol Myers Squibb is set to release a new schizophrenia treatment in the United Kingdom for the same price it’s listed for in the United States, a decision that will certainly please those in the White House who have fought to get Americans the same prices offered overseas.

The announcement, made by Bristol on Monday, follows a push from President Donald Trump for U.S. drugmakers to lower prescription drugs for Americans to the greatest extent possible. Bristol’s approach to the United Kingdom market aligns with the White House’s strategy to secure lower drug prices in the United States.

The pharmaceutical company has never before brought its price for a drug to parity across the United States and the United Kingdom. Adam Lenkowsky, chief commercialization officer at Bristol, said that the drug company is prepared to pull its drug, Cobenfy, from the European nation’s market if the relevant government authorities do not agree to the price listed in the United States, at $1,850 a month.

“Our intention is to work with NICE and NHS to make this medicine available, but we are prepared to make the difficult decision to walk away if they cannot better recognize the value our medicine brings to patients and society,” Lenkowsky said in a statement.

“We agree with the Trump Administration that other countries need to pay their fair share,” he added.

Cobenfy has not yet been approved for sale in the United Kingdom. Bristol plans to file for approval in the coming weeks and expects to receive approval sometime next year, according to the Financial Times.

Last year, the research group RAND found that Americans pay significantly more for prescription drugs than other countries. The research pegged the inflated price at 2.78 times what is charged in other countries.

The Trump administration is determined to end that trend, and has pointed to drug manufacturers.

“The United States has less than five percent of the world’s population and yet funds around three quarters of global pharmaceutical profits,” a May 12 White House executive order on drug prices says. “This egregious imbalance is orchestrated through a purposeful scheme in which drug manufacturers deeply discount their products to access foreign markets, and subsidize that decrease through enormously high prices in the United States.”

The order aims to pressure drugmakers to push for parity between prices for its drugs in the United States and elsewhere in the world. The president last week said that other countries have treated Americans unfairly when it comes to drug prices.

“For years, we’ve been paying for a pill $100 and they’re paying $10,” the president said on Fox News last week. Trump suggested he intends to pressure other countries into raising drug prices to offset the costs of making new drugs for Americans.

“The drug companies agree that I’m right, and the countries, if they don’t agree, I’ll use tariffs to get them to agree,” Trump said. “We’re going to be reducing drug costs over the next year, year and a half by not 50% or 60%, by 1,000% … You’re talking about a monumental change in health care that’s going to affect Medicare, Medicaid, even Social Security.”

.@POTUS: “For years, we’ve been paying sometimes for a pill, $100, and [other countries] are paying $10… We’re going to be reducing drug costs over the next year, year and a half… You’re talking about a monumental change in healthcare.” pic.twitter.com/Pxnj8vU1hc

— Rapid Response 47 (@RapidResponse47) September 18, 2025

WASHINGTON—President Donald Trump promised Sunday that his administration is “very strongly” examining the string of transgender violence throughout the United States.

The president spoke with reporters aboard Air Force One late in the day as he traveled home from a memorial service for Charlie Kirk. Approximately 90,000 people attended the memorial at State Farm Stadium in Arizona, including many members of the president’s administration, who eulogized their murdered friend with emotion and called for Americans to follow Jesus Christ throughout the five-hour service.

Aboard Air Force One on the way home, Trump joined the press at the back of the plane to take questions. The Daily Wire pointed out to the president that Kirk’s alleged killer lived with his trans-identifying roommate and lover, that the horrific Annunciation Catholic School shooting was committed by a trans-identifying killer, and that the Covenant School shooting was committed by a trans-identifying killer, among other recent examples.

While he stressed that his administration is looking into the matter, Trump noted that he can’t make a definitive statement on the topic yet.

“You know, we’re looking at that,” the president responded gravely, asking, “What’s the reason for it?”

“Yeah, there seems to be something,” he reflected. “But we’re looking at it very strongly. Something seems to be going on.”

Court documents first obtained by The Daily Wire show that the man who attempted to kill Supreme Court Justice Brett Kavanaugh identifies as a transgender woman and was deeply mentally ill and suicidal. A footnote in the filing from Nicholas Roske’s defense attorneys, obtained exclusively by The Daily Wire, states that the defense will not use Roske’s legal name “out of respect” for the would-be assassin.

Asked by The Daily Wire about this development, the president responded: “Wow.”

A portrait of Charlie Kirk is displayed behind White House Press Secretary Karoline Leavitt (Photo by Andrew Harnik/Getty Images)

“It’s too bad,” he said, “It’s a very sad thing going on with that and I’ll have to take a look at it.”

“We have to protect our Supreme Court justices,” the president said. “Justice Kavanaugh is a great guy, I mean, it’s horrible. He’s been through a lot with this. All of them have, in a way, [President Joe Biden’s administration] didn’t give them proper protection.”

The president emphasized that his administration is determined to protect the justices, saying, “We have to protect the Supreme Court, we have to.”

During Monday’s press briefing at the White House, Press Secretary Karoline Leavitt similarly told The Daily Wire that transgender violence is “definitely something worth looking into.”

“I think anyone who denies that at this point is being willfully ignorant,” Leavitt argued. “And the administration is taking it seriously, all causes of violence and why these people would be driven to such evil and such hatred. And there [are] probably many answers to that question, but the administration is really focused on all of them.”

The White House press secretary said for individual investigations and cases, the FBI and Justice Department “are leading those.”

“But as for this overall violence and domestic terrorism that we’re seeing, the White House and the President’s policy team will be leading the charge,” she added. “And that really begins with designating Antifa as a domestic terrorist organization. And I can assure you there will be additional actions to come.”